openPR Logo
Press release

Lawsuit filed for Investors in shares of Workhorse Group Inc. (NASDAQ: WKHS)

03-17-2021 08:07 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Workhorse Group Inc. (NASDAQ: WKHS) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in Workhorse Group Inc. (NASDAQ: WKHS) shares over alleged securities laws violations.

An investor, who purchased shares of Workhorse Group Inc. (NASDAQ: WKHS), filed a lawsuit over alleged violations of Federal Securities Laws by Workhorse Group Inc.

Investors who purchased shares of Workhorse Group Inc. (NASDAQ: WKHS) have certain options and for certain investors are short and strict deadlines running. Deadline: May 7, 2021. NASDAQ: WKHS investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Loveland, OH based Workhorse Group Inc., a technology company, designs, manufactures, builds, and sells battery-electric vehicles and aircraft in the United States. Workhorse Group Inc. submitted a bid to participate in the United States Postal Service’s “next generation delivery vehicle” (NGDV) search, which would replace an aging fleet of more than 200,000 trucks. Final bids were submitted on July 14, 2020. In a July 21, 2020 article published, Steve Schrader, Workhorse’s CFO, provided an update on the USPS contract estimated to be worth $6 billion. According to the article, “Schrader said he can’t discuss too much about the process at this point, but Workhorse is the only all-electric option” and Schrader reportedly stated “[w]hat I will say is our all-electric is probably the perfect vehicle for them. . . .”
On February 23, 2021, USPS awarded its contract to finalize the design of the NGDV and assemble 50,000 to 165,000 vehicles over 10 years to Oshkosh Defense, beating electric-vehicle maker Workhorse Group Inc.. According to USPS, “the vehicles will be equipped with either fuel-efficient internal combustion engines or battery electric powertrains and can be retrofitted to keep pace with advances in electric vehicle technologies.”

Shares of Workhorse Group Inc. (NASDAQ: WKHS) declined $42.96 per share on February 4, 2021 to $12.50 per share on February 23, 2021.

The plaintiff claims that between July 7, 2020 and February 23, 2021, the defendants made false and/or misleading statements and/or failed to disclose that the Company was merely hoping that USPS was going to select an electric vehicle as its Next Generation Delivery Vehicle, and had no assurance or indication from USPS that this was the case, that the Company had concealed the fact that – as revealed by the postmaster general in explaining the ultimate decision not to select an electric vehicle – electrifying the USPS’s entire fleet would be impractical and astronomically expensive, and that as a result, defendants’ statements about Workhorse’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Workhorse Group Inc. (NASDAQ: WKHS) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Workhorse Group Inc. (NASDAQ: WKHS) here

News-ID: 2258118 • Views: 453

More Releases from Shareholders Foundation

Lawsuit filed for Investors in shares of CytoDyn Inc. (OTC: CYDY)
An investor, who purchased shares of CytoDyn Inc. (OTC: CYDY), filed a lawsuit over alleged violations of Federal Securities Laws by CytoDyn Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of CytoDyn Inc. (OTC: CYDY) have certain options and for certain investors are short and strict deadlines running. Deadline: May 17, 2021. OTC: CYDY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Investigation announced for Long-Term Investors in shares of SolarWinds Corporat …
An investigation on was announced concerning potential breaches of fiduciary duties by certain directors and officers of SolarWinds Corporation. Investors who are current long term investors in SolarWinds Corporation (NYSE: SWI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: SWI stocks follows a lawsuit filed against SolarWinds Corporation
Update in Lawsuit for Investors in shares of Merit Medical Systems, Inc. (NYSE: …
An investor in Merit Medical Systems, Inc. (NYSE: MMSI) shares filed a lawsuit in December 2019, against Merit Medical Systems, Inc. over alleged violations of Federal Securities Laws. Investors who purchased shares of Merit Medical Systems, Inc. (NYSE: MMSI) prior to February 2019 and continue to hold any of those shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. After the market
Deadline on May 3rd coming up in Lawsuit for Investors in Velodyne Lidar, Inc. ( …
A deadline is coming up on May 3, 2021 in the lawsuit filed for certain investors of Velodyne Lidar, Inc. (NASDAQ: VLDR) over alleged securities laws violations by Velodyne Lidar, Inc. Investors who purchased shares of Velodyne Lidar, Inc. (NASDAQ: VLDR) have certain options and there are strict and short deadlines running. Deadline: May 3, 2021. NASDAQ: VLDR stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Workhorse

Investigation announced for Investors in shares of Workhorse Group Inc. (NASDAQ: …
An investigation was announced for investors of Workhorse Group Inc. (NASDAQ: WKHS) shares over potential securities laws violations by Workhorse Group Inc. in connection with certain financial statements. Investors who purchased shares of Workhorse Group Inc. (NASDAQ: WKHS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Workhorse Group Inc.
Textile Printing Machine Market Rising Demands With Keyplayer: M&r Printing Equi …
This detailed market study focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The analysis also provides details of each segment in the global textile printing machine. According to the report, growing demand for sustainable printing is expected to drive the growth of textile printing machine market
Folding and Packing Machine Market Forecast 2012-2022: Vastex, Anatol Equipment, …
Folding and Packing Machine Market Research 2017 A market study ” Global Folding and Packing Machine Market ” examines the performance of the Folding and Packing Machine market 2017. It encloses an in-depth Research of the Folding and Packing Machine market state and the competitive landscape globally. This report analyzes the potential of Folding and Packing Machine market in the present and the future prospects from various angles in detail. The Global
Fulham Wireless Programmable WorkHorse LED Drivers Receive Pennwell 2017 Sapphir …
Integrated wireless programmable one of the first clever lighting features from Fulham designed to lay the foundation for smart lighting solutions. Hawthorne, CA, USA -- Fulham Co., Inc., a leading supplier of lighting components and electronics for commercial and specialty applications, has received a 2017 Sapphire Award from LEDs Magazine in the LED Drivers Category. The Award was presented for Fulham's line of WorkHorse outdoor, programmable LED drivers with integrated wireless
Fulham Introduces WorkHorse LED Extreme Driver Family for Outdoor and High-Power …
First Drivers to Feature Integrated Wireless Controls for Easy Configuration and Installation. Hawthorne, CA, USA -- Fulham Co., Inc., a leading supplier of lighting components and electronics for commercial and specialty applications, has released the WorkHorse LED Extreme family of constant current, programmable drivers specifically designed for outdoor and high-power applications. WorkHorse LED Extreme drivers are intelligent, programmable LED drivers built for harsh environments. The WorkHorse LED Extreme family is composed of
Despite Progress Injectable/Infusible Antimetabolites Remain the Workhorse in Ca …
(Amherst, NH) – The world of oncology continues to evolve as physician specialists and researchers apply the latest knowledge and therapies to treat patients afflicted with cancer. Several advances have prolonged survival and provided hope to patients and their loved ones. Targeted drugs - typically monoclonal antibodies that bind to a specific cell surface receptor to affect a therapeutic response – have produced many success stories in treating